Please ignore this javascript. This is for analytics tracking. Substance Use Disorders Institute Faculty and Staff | University of the Sciences | Philadelphia, PA

SUDI Medical Cannabis Education Faculty, Guest Lecturers and Planning Committee Members


Christine RousselChristine Roussel, PharmD, BCOP;  Certification Course Director, planning committee, presenter

Dr Christine Roussel is a Board-certified Oncology Pharmacist with a Bachelors. in Toxicology and Doctorate  in Pharmacy from University of the Sciences. Her passions include occupational exposure to hazardous drugs, compounding and legislative topics, such as Medical Cannabis.  

She is Assistant Director of Pharmacy at Doylestown Hospital, an adjunct professor at USciences, and co-founder of the American Society of Cannabis Pharmacists.  

Dr. Roussel is a facilitator and content author for Medisca (LP3 Network), for whom she provides over 100 hours of CE on Sterile, Non-Sterile and Hazardous Drug compounding throughout the US and Canada, as well as serves as a pharmacy consultant specializing in compliance and compounding facility design.

Maria Foy, PharmD, BCPS, CPEMaria Foy, PharmD, BCPS, CPE  is a clinical pharmacy specialist in Palliative Care at Abington Hospital Jefferson Health, a 660 bed community teaching hospital outside of Philadelphia.  Maria graduated from Temple with a BS in Pharmacy and holds a PharmD from USciences.

A Certified Pain Educator (CPE) and board certified in pharmacotherapy (BCPS),  Maria received the Joe E. Smith Award from the PA Society of Health System Pharmacy in 2017, the states’ recognition for excellence in clinical practice. She was recognized with  a Patient Safety Award at Abington Jefferson Health for her work to develop safe opioid prescribing practices.

Adam Lake, MD, FAAFP, AAHIVS, FACMQAdam C. Lake, MD, FAAFP, AAHIVS, FACMQ practices at Penn LGHealth in Lancaster, where he is on the faculty of the family medicine residency program.  His areas of expertise include addiction medicine, HIV/AIDS, Hep-C, and lesbian, gay, bisexual, and transgender health.

Dr Lake studied linguistics & biochemistry at Grinnell College, medicine at Temple University, permaculture & traditional medicine in Latin America, & completed a fellowship in population health. Dr Lake is a registered physician in the PA Medical Marijuana program, and lectures locally and regionally on treatment of opioid use disorder and medical marijuana. 

Chosen LeeChosen Lee, B.S. Pharmacy, PharmD is a registered pharmacist in Pennsylvania, with a B.S. in Pharmacy, and a PharmD from the Philadelphia College of Pharmacy at the University of the Sciences. She currently practices as a Medical Cannabis Clinical Pharmacist and Medical Education Outreach Coordinator at a Cure Pennsylvania licensed dispensary, responsible for verifying and reviewing patient certifications, providing consultations and therapeutic recommendations and management support to patients; and providing education and organizing outreach events for healthcare professionals.She also serves on staff at Omnicare as a Long Term Care Pharmacist, responsibilities including Drug Utilization and medication safety, risk management, and dosing reviews for Long Term Care facilities, and hospice, palliative care and other special population group patients.

She has served as an Adjunct Instructor in Principles of Pharmacotherapeutics Laboratory at the University of the Sciences in Philadelphia and as a preceptor for pharmacy students for University of the Sciences, Jefferson and Temple Schools of Pharmacy in various practice settings. Her past professional experience includes community pharmacy, retail pharmacy management, and pharmacy benefit management practice. Her certifications include Medical Cannabis, Pharmacy-Based Immunization, and Medication Therapy Management, and Risk Evaluation and Mitigation Strategy. Her special interests include Pharmacogenomics, Hospice/Palliative Care. Dr Lee is an active member of the American Pharmacists Association and the American Society of Cannabis Pharmacists

Additional Medical Cannabis Presenters

J. Cobb ScottJ.Cobb Scott, PhD is an Assistant Professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania, Staff Psychologist at the Crescenz (Philadelphia) VA Medical Center, and Co-Director of the CMCVAMC’s Neuropsychology Postdoctoral Residency. He completed a B.A. in Psychology at Wesleyan University, a Ph.D. in Clinical Psychology with specialization in Neuropsychology at the San Diego State University/ University of California, San Diego Doctoral Program, clinical internship at the VA Connecticut Healthcare System, and a postdoctoral fellowship at Yale University. Broadly, his research interests include the cognitive neuroscience and neuropsychology of psychiatric disorders and substance use. More specifically, Dr. Scott is interested in understanding relationships between cannabis use, cognitive functioning, and mental health; characterizing dysfunctional neurocircuitry in PTSD; understanding the brain-behavior overlap between PTSD and substance abuse; and examining the relationship between neuropsychological and everyday functioning outcomes, such as treatment response, in psychiatric disorders. He has published over 50 research articles and received grants from both the NIH and the Department of Veterans Affairs.

Mary Ann DiLiberto, BS, RN, CCRC, ACRP-PM is the Program Manager for the Center for Clinical Pharmacology at Children’s Hospital of Philadelphia.  Previously, she was Clinical Research Manager for the Division of Critical Care Medicine at CHOP. Mary Ann has twelve years of Pediatric Critical Care Research experience in managing various clinical studies. She also served as the Coordinator for the NICHD funded Collaborative Pediatric Critical Care Research Network at CHOP. Mary Ann was instrumental in transforming the Critical Care Research infrastructure at CHOP by growing and leading the research staff from one employee to thirteen employees who now cover the Pediatric Intensive Care Unit 24 hours a day 7 days a week for research enrollments and study procedures. In October, 2013, she was awarded the first Clinical Research Coordinator Award at CHOP from among 300 CHOP research coordinators in recognition of her exceptional contributions to clinical research.

Athena Zuppa, MD, MSCE is an Associate Professor of Pediatric Critical Care Medicine at The University of Pennsylvania and Director of the Center for Clinical Pharmacology, with a Master's of Science in Clinical Epidemiology.  Her career has focused on improving drug delivery of both older and newer medications to critically ill children, and has expanded to include the adult population, novel assay development and pharmacogenomics. Her experience in pharmacology, biostatistics, epidemiology, trial design, multi-site clinical trials combined with her role as a pediatric intensivist at CHOP has led to her interest in investigating the utility of medical cannabis in both children and adults.

The Center for Clinical Pharmacology, under her direction, houses a state-of-the-art Bioanalytical Lab capable of small volume assays in most biologic specimens. In addition, we are experts in pharmacometric modeling and simulation. In 2009 she received an R01 entitled, “The Impact of Pharmacology on Sedation Assessments in Children who are Mechanically Ventilated,” sponsored by NHLBI. This multi-site study examined the impact of pharmacokinetics and pharmacogenetics on the effect of morphine and midazolam in critically ill children with acute respiratory failure, using sophisticated pharmacokinetic techniques including non-linear mixed effects modeling.  In 2012 she was awarded a second R01 from the NHLBI entitled “Hypothermia’s Impact on Pharmacology.” This multi-site trial is examining the impact of deliberate hypothermia in children after cardiac arrest on drug disposition and metabolism. At a national level, she is actively involved with many aspects of pediatric clinical pharmacology, and served as a voting member of the Food and Drug Administration Anesthesia and Life Support Medications Subcommittee. She is also the CHOP PI for a joint Clinical Pharmacology T32 training program in collaboration with Thomas Jefferson University, funded through co-sponsorship between the NICHD and NIGMS. 

Medical Cannabis Education: Planning Committee Members

Joseph Morgan

Joseph Morgan, MD, AACM; Certification course planning committee, presenter

Graduated from Penn State and Drexel Med (Hahnemann). He is Pennsylvania's first Diplomate of the American Academy of Cannabinoid Medicine based on clinical Cannabis training in California and Israel and original research culminating in a US patent pending. That patent, "Use of cannabinoids and terpenes for the treatment of organophosphate and carbamate toxicity" is licensed to Intiva Biopharma for developing FDA-approvable drugs to treat chemical war nerve gas toxicities and other indications. Currently Medical Monitor at Onconova Therapeutics in Newtown, PA (MDS/AML investigational therapies), Dr Morgan also consulted for a Pennsylvania Cannabis Applicant but has no current relationships with any Pennsylvania or other Cannabis companies. He specializes in historical medical uses of Cannabis, regulatory history, comparative drug efficacies and toxicities, rationale pharmacotherapy, and uses of FDA-approved dronabinol. His medical practice was in Drug & Alcohol Rehab including at the Department of Medicine at Eagleville Hospital prior to a drug safety and clinical research career in pharma and biotech.

Dr Morgan is an advisor for USciences’ medical cannabis continuing education course content, and has been a Dean’s Professor for University of the Sciences and guest lecturer for the Medical Cannabis Certification course, as well as a Guest Scientist at Wm Patterson U in Wayne, NJ (Biology/cannabinoid research lab).

Andrew Peterson, PharmD, PhD, Executive Director, SUDI

Vince Paul, RPh, Manager of Continuing Education, Alpha Zeta Omega National Pharmaceutical Fraternity, Philadelphia Alumni Chapter (AZO)


The following speakers, faculty, and/or  planning committee members disclose as follows, if they, or a primary relative have a  financial interest/arrangement or affiliation with one or more organizations in the last 12 months that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Mary Ann DiLiberto, RN and Athena Zuppa, MD
Research grant support from Zelda Therapeutics.

Maria Foy, PharmD
Employed part-time as a dispensing pharmacist, Restore PA, a PA cannabis dispensary, that does not grow, process or sell cannabis products

Chosen Lee, PharmD
Employed as a dispensing pharmacist, Cure Pennsylvania, a PA cannabis dispensary, that does not grow, process or sell cannabis products.

Joseph Morgan, MD, AACM
Consultant, Parea BioSciences (Applicant), Pennsylvania
Consultant, Intiva BioPharma, Inc
US Patent Pending related to Cannabinoids
Common shares, GW Pharma stock

Andrew M. Peterson, PharmD, PhD, FCPP
Medical Advisory Board Member, Holistic LLC  - New Jersey License Applicant

The following speakers, faculty, and/ or planning committee members report that they, or a primary relative, have no actual or potential conflict of interest in relation to medical cannabis in the preceding 12 months.

Christine Roussel, PharmD, BCOP
Adam C. Lake, MD
J. Cobb Scott, PhD


Andrew M. Peterson, PharmD, PhD, FCPP
Executive Director, Substance Use Disorders Institute


University of the Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495